Oral LTX - Donor Management and Organ Allocation

314 - The ISHLT 2017 Updated DCD Registry Report

Presentation Number
314
Presenter
Co-Authors

Previous Eposter
304 - Survival in Intermacs 1 & 2 Patients After LVAD Therapy: Does Chronicity of Heart Failure Matter?

Next Eposters
322 - Bloodstream Infections in Left Ventricular Assist Device Recipients Awaiting Transplantation
335 - Third Party HLA Antibody as a Surrogate Marker for Treatment of Non-HLA AMR
358 - Ex-vivo Lung Perfusion - 10 Year Follow-up of the First Performed Double LTX With Marginal Donor Lungs Evaluated Using EVLP
365 - Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart Function
366 - Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial Hypertension
367 - OPUS Registry: Switching to Macitentan From Other Endothelin Receptor Antagonists (ERAs)
376 - Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation
377 - Survival and Outcome in Pediatric Myocarditis - 3 Year Data from the German Multi-center Prospective Myocarditis Registry: “MYKKE”
378 - Acute Decompensated Heart Failure in the Pediatric Population: A Report from the Pediatric Cardiac Critical Care Consortium (PC4)
432 - Hemodynamic Response to Continuous-flow Left Ventricular Assist Device Ramp Test and Volume Loading Predicts Successful Weaning from the Device Support